Keywords: choongwae, pharma, launch, generic, form, merck, co
Choongwae Pharma to launch generic form of Merck & Co's Primaxin
Article | 14 June 2004
South Korea-based drug and intravenous fluid producer Choongwae Pharma has developed a generic version of Merck & Co's carbapenem antibiotic Primaxin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
